Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1996-10-09
1999-12-21
Huang, Evelyn Mei
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514256, 514348, 514349, 514350, 544333, 5462751, 5462727, 5462744, 546256, A61K 3144, C07D40112
Patent
active
060049855
ABSTRACT:
This invention is directed to monocyclic N-heterocyclics which are substituted by acyclic or cyclic thio derivatives which are useful as anti-coagulants. This invention is also directed to pharmaceutical compositions containing the compounds of the invention, and methods of using the compounds to treat disease-states characterized by thrombotic activity.
REFERENCES:
patent: 4064169 (1977-12-01), Hamano et al.
patent: 5332822 (1994-07-01), Misra
patent: 5451700 (1995-09-01), Morrissey
Delgado JN and Remers WA. Textbook of Organic Medicinal and Pharmaceutical Chemistry. Ninth Edition. pp. 30-31, 1991.
Tidwell, R. et al., "Strategies for Anticoagulation with Synthetic Protease Inhibitors, Xa Inhibitors Versus Thrombin Inhibitors," Thrombosis Research, (1980) 19:339-349.
Wagner, G. et al., "Synthese von a-a'-Bis[amidinobenzyliden]-und a-a' Bis-[amidinobenzyl]-cycloalkanonen," Pharmazie, (1977) 32,141-145.
Sturzebecher, J. et al., "Cyclic Amides of N.alpha.-arysulfonylaminoacylated 4-amidinophenylalanine--Tight Binding Inhibitors of Thrombin," Thrombosis Research, (1983) 29:635-642.
Kikumoto, R. et al., "Selective inhibition of Thrombin by (2R,4R)-4-Methyl-1-[N.sup.2 -[(3-methyl-1,2,3,4-tetrahydro-8-quinolinyl)-sulfonyl]-L-arginyl)]-2piperi dinecarboxylic Acid," Biochemistry, (1984) 23:85-90.
Sturzebecher, J. et al., "Synthetic Inhibitors of Serine Proteinases XXIII, Inhibition of Factor Xa by Diamidines", Thrombosis Research, (1980) 17:545:548.
Chauhan , P. et al., "Effect of new diamidines against Leishmania donovani infection," Indian Journal of Experimental Biology, (1993) 31:196-198.
Ashley, J. et al., "The Search for Chemotherapeutic Amidines. Part XVI. Amidinoanilino-1,3,5-triazines and Related Compounds", J. of the Chemical Society, (1960) 4525:4532.
Geratz, J. et al., "The Inhibition of Urokinase by Aromatic Diamidines" Thrombos. Diathes haemorrh. (Stuttg.), (1975)33:230-243.
Geratz, J. et al. "Novel Bis (benzamidino) Compounds with an Aromatic Central Link. Inhibitors of Thrombin, Pancreatic Kallikrein, Trypsin, and Complement" J. of Medicinal Chemistry, (1976) 19(5):634-639.
Chauhan, P. et al., "Antiparasitic Agents: Part VI--Synthesis of 1,2-,1,3-&1,4-Bis(4-substituted aryloxy)benzenes & Their Biological Activities", Indian Journal of Chemistry, (1988) 27B:38-42.
Kaiser B, Hauptmann J. Cardiovascular Drug Reviews, 12, 225-236, 1994.
Kochanny Monica J.
Morrissey Michael M.
Ng Howard P.
Berlex Laboratories Inc.
Huang Evelyn Mei
Roth Carol J.
LandOfFree
Thio acid derived monocylic N-heterocyclics as anticoagulants does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Thio acid derived monocylic N-heterocyclics as anticoagulants, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Thio acid derived monocylic N-heterocyclics as anticoagulants will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-505571